HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

AHR

American Healthcare REIT, Inc.

Real Estate — REIT - Healthcare Facilities

American Healthcare REIT, Inc., a Maryland-based self-managed REIT, owns and operates a diversified portfolio of clinical healthcare real estate across the U.S., U.K., and the Isle of Man. Its focus includes senior housing, skilled nursing facilities (SNFs), outpatient medical (OM) buildings, and other healthcare-related properties. The company utilizes a fully integrated management platform and operates senior housing under the RIDEA structure. In addition to owning and operating properties, it has originated and acquired secured loans and may pursue other real estate-related investments opportunistically. The REIT seeks income-generating assets and selectively develops healthcare properties. It has elected to be taxed as a REIT under the U.S. Internal Revenue Code and intends to maintain compliance with REIT requirements. American Healthcare REIT, Inc. is based in Irvine, United States.

Strong Buy 1.4 / 5 15 analysts
$50.70
$-0.56 (-1.09%)
Target: $60.40 (19.1%)

Price History

52-Week Range
Sign in to add AHR to a watchlist or set price alerts.

Fundamentals

Market Cap$11.49B
P/E Ratio (TTM)94.24
Forward P/E64.65
EPS (TTM)$0.59
Dividend Yield1.79%
Profit Margin4.23%
Revenue Growth20.90%
ROE3.49%
Debt/Equity47.61
Recommendation Strong Buy 1.4
Analyst Target$60.40
Analysts15
Next Earnings Aug 6, 2026 AMC
Indexes -

Technical Indicators

RSI (14)56.2
Beta0.78
SMA 20$55.85
SMA 40$52.26
52-Week High$58.70
52-Week Low$38.68
50-Day Avg$51.65
200-Day Avg$49.48
Avg Volume$3.23M
Volume$1.10M

Performance Analysis

BULLISH

AHR shows predominantly bullish signals based on its fundamentals and technicals.

~ Trading at 60% of its 52-week range.
+ RSI at 56.2 shows positive momentum.
~ Price dropped below the 50-day average but remains above the 200-day — possible short-term weakness.
- P/E of 94.2 is elevated — the market expects high growth or it may be overvalued.
+ Strong revenue growth of 20.9% year-over-year.
+ Wall Street consensus is "Strong Buy" from 15 analysts.
+ Average analyst target of $60.40 implies 19.1% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Aug 01, 2026 04:16 UTC

Back to Screener Export Report